Wed, Nov 26, 2014, 11:59 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Chembio Diagnostics, Inc. Message Board

samsato18 68 posts  |  Last Activity: 10 hours ago Member since: Aug 20, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Sono, Sailing, Scorekeeper, Kursorrie....

    Kursorrie last posted that he knew how long of a commute LS had. (back in Sep 2013 when he established his new the disgruntled employee theory still rings true for this person) Either all of these people are the same person who try to bait others for responses or both of them work in adjoining cubicles. Sad....

  • samsato18 samsato18 Nov 25, 2014 6:45 PM Flag

    I have to disagree with you here. CMS did the right thing on payment. The market requires another method for screening...more choice is always better.

    But the question remains if people will use/request it over other tests or simply go straight to colonoscopy - which is still the gold standard. I seriously doubt that the general public understands sensitivity and specificity to the degree that all of you do. (We will know with a few quarters if this is the monster that Wall Street has made it out to be - no company can hide from their own numbers.)

  • samsato18 by samsato18 Nov 25, 2014 12:46 PM Flag

    And I am also scheduling my colonoscopy for 2015. This company has been good about Colon Cancer awareness evidenced by the longer waiting lines for the scope.

    And for disclosure, I have not taken a FIT/ FOBT/ or other Genetic CC test.

  • Reply to

    Sono Withdrawl

    by samsato18 Nov 14, 2014 2:29 PM
    samsato18 samsato18 Nov 17, 2014 12:31 PM Flag

    Sono - If you were a serious investor, you should buy some shares...stop your complaining and do us all a favor.

  • Reply to

    Sono Withdrawl

    by samsato18 Nov 14, 2014 2:29 PM
    samsato18 samsato18 Nov 17, 2014 10:13 AM Flag

    Ha Ha! Sono - if you left this board, half of the insane postings would end because they are all from you! What a dope!

  • samsato18 by samsato18 Nov 14, 2014 2:29 PM Flag

    Sono...are you OK? have only posted once today! Why are you picking on MO? Ideas flow from contributions, not bashing.

    As I recall, it was you who started all the LS bashing, about the same time you freaked out that DPP HIV would never get CLIA Waiver. Turn over a new leaf...get a new ID and help build this company. Contribute to the discussion...what's hot and emerging other than ebola? They do read the message board.

  • Reply to

    Stupid cheap

    by sonomaca Nov 10, 2014 4:45 PM
    samsato18 samsato18 Nov 11, 2014 5:02 PM Flag

    If LS' plan is to get to 3% holding, then he has 200,000 shares yet to sell. No matter how you dice the news from last week, it was all positive. 1 more week of selling in my viewpoint.

  • Reply to


    by sonomaca Nov 9, 2014 2:25 AM
    samsato18 samsato18 Nov 9, 2014 7:39 AM Flag

    Sure...Ebola would make headlines and makes sense with the already developed Febrile panel. But for Maximum impact:

    But HIV-Syphilis puts Chembio on everyone’s top investment pick. EVERY hospital lab in America is trying to put Syphilis on their testing menu and each large diagnostic company has plans to develop an automated Syphilis test for their instruments. (this requires CLIA Moderately Complex status only). Public health needs the CLIA Waiver. This is a first to market game changer.

    HIV-Syphilis is a killer application for DPP. Chembio has a strong future.

    Sentiment: Strong Buy

  • Reply to

    See the Zachs report just released

    by moscuba Nov 7, 2014 12:34 PM
    samsato18 samsato18 Nov 7, 2014 6:11 PM Flag

    I noticed that IT has attempted to respond 3 or 4 more times to something. I would encourage him to stay on this board if has something valuable to share or if he thinks we should be shorting CEMI, like I will be shorting EXAS. I would love to know his reasons...on EXAS he knows mine.

  • Reply to

    CEO Sperzel

    by sailingaway82 Nov 6, 2014 10:52 AM
    samsato18 samsato18 Nov 7, 2014 10:46 AM Flag

    I am raising a glass and toasting retsac65 tonight! “Hear ye and Hear him!"

  • Saw this headline today which should bode well for all diagnostic kit particular Chembio. Also, in speaking with laboratory professionals this week, they all would like a Flu A/B test that can also detect various febrile diseases like Ebola and Malaria. In larger health care systems, even in more rural areas, they get patients with recent travel to Africa. Imagine all the concern over Ebola during this flu season...

  • Reply to

    all you smart ones

    by tpmavrakos Nov 3, 2014 5:21 PM
    samsato18 samsato18 Nov 3, 2014 9:02 PM Flag

    It will take longer than 4 years to gain complete physician acceptance of this test. And understanding that other genetic tests haven’t pushed out FIT and FOBT yet, neither will Cologuard. Great test. Hopefully the company can continue to raise more cash for this long launch and future products.

    Sentiment: Strong Buy

  • Reply to

    LS sold his 100K shares

    by chart_watcher99 Nov 3, 2014 9:22 AM
    samsato18 samsato18 Nov 3, 2014 8:51 PM Flag

    Hi Sailing and Sono:

    With all due respect, there is nothing to gain from your contributions on this message board. We have CLIA Waiver, multiple live projects, grant awards, research projects, and royalty streams. This is all just a beginning. All of us old timers are in the money...and all of my concerns with Chembio evaporated when CLIA Waiver came through. DPP is next generation rapid diagnostic testing.

    I have a deep respect for Larry Siebert for his vision and his timing of stepping aside for a great commercial CEO in JS. (Regardless of your “feelings,” there would be no Chembio if LS wasn’t involved.) I am curious about LS’ new position as a Senior M&A advisor for diagnostics. My guess is that he is still involved with shareholder value at Chembio.

    See you from time to time...probably on the EXAS board. Long live the longs!

    Sentiment: Strong Buy

  • Reply to

    Revs for next year

    by sonomaca Nov 1, 2014 11:25 PM
    samsato18 samsato18 Nov 2, 2014 10:04 AM Flag

    Sono...don’t forget royalty payments. The Biorad Geenius HIV Confirmatory test appears to be a complete replacement of Western Blot confirmatory testing. I would not be surprised to see guidelines call this test the new gold standard soon.

  • Reply to

    This has been an awesome week

    by chart_watcher99 Oct 31, 2014 9:36 AM
    samsato18 samsato18 Oct 31, 2014 1:01 PM Flag

    Chart - completely agree! If anyone had a concern about Chembio’s future before, they should have none now. The CLIA Waiver was the last overhang. Lots of work to be done to be sure, but all the doors have been opened.

  • samsato18 by samsato18 Oct 30, 2014 10:05 AM Flag

    All the initial heavy lifting is starting to pay-off!

  • Just a heads up that OraQuik now has competition for their $35 MM Oral franchise

  • Reply to

    Orasure test for Ebola virus? Are they working on it?

    by pm275 Oct 15, 2014 7:47 PM
    samsato18 samsato18 Oct 30, 2014 8:04 AM Flag

    Sono - Yeah, I am an ignoramus...sure. Several rapid tests in EU are coming to the forefront. Another one announced recently comes with the backing of Scientists from the French Atomic Energy Commission (CEA). They teamed up with pharma company Vedalab for an Ebola 15 min rapid test. This would be a small lateral flow test paired with a hand-held device.

    With Ebola testing, the only advantage Orasure and Chembio will have is the ability to test with oral samples.

  • samsato18 samsato18 Oct 30, 2014 7:50 AM Flag

    pilo: Don't tread on those attempting to make Wisconsin have no idea what you are talking about.

  • Reply to


    by samsato18 Jul 23, 2014 5:30 PM
    samsato18 samsato18 Oct 28, 2014 8:48 PM Flag

    Ah are in love with your EXAS. I have mentioned before that I agree with the pieces of data you represent. Be good to yourself and have a plan when EXAS reverses. It’s a $2+ Billion MCap with no sales (By comparison, Quest, who also has a non-invasive molecular Colon Cancer test is only valued around $8 Billion). You don’t seem to be good with never mind.

4.48-0.02(-0.44%)Nov 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
SeaDrill Limited
NYSEWed, Nov 26, 2014 4:01 PM EST
KLA-Tencor Corporation
NasdaqGSWed, Nov 26, 2014 4:00 PM EST
TASER International Inc.
NasdaqGSWed, Nov 26, 2014 4:00 PM EST